Showing 1 - 19 results of 19 for search '"Theoret M"', query time: 1.13s Refine Results
3
4
Academic Journal

Authors: Bouchkouj N; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Lin X; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Wang X; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Przepiorka D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Xu Z; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Purohit-Sheth T; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Theoret M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Source: The oncologist [Oncologist] 2022 Oct 01; Vol. 27 (10), pp. 892-899.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

HTML Full Text     PDF Full Text
5
Academic Journal

Authors: Bouchkouj N; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Zimmerman M; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Kasamon YL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Wang C; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Dai T; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Xu Z; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Wang X; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Theoret M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA., Purohit-Sheth T; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., George B; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Source: The oncologist [Oncologist] 2022 Jul 05; Vol. 27 (7), pp. 587-594.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

HTML Full Text     PDF Full Text
6

Authors: Theoret M; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland., Shah M; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Rahman A; Division of Cancer Pharmacology II, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.

Source: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2022 Mar; Vol. 20 (3), pp. 148-150.

Publication Type: Interview

Journal Info: Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: PubMed not MEDLINE; MEDLINE

PDF Full Text
7
Academic Journal

Authors: Kasamon YL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Price LSL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Okusanya OO; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Richardson NC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Li RJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Ma L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Wu YT; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Theoret M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Gormley NJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Source: The oncologist [Oncologist] 2021 Oct; Vol. 26 (10), pp. 879-886. Date of Electronic Publication: 2021 Jul 01.

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

HTML Full Text     PDF Full Text
8
Academic Journal

Authors: Merino M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Kasamon Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Li H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Ma L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Leong R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Zhou J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Reaman G; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Chambers W; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Richardson N; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Theoret M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Gormley N; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2022 Aug; Vol. 69 (8), pp. e29602. Date of Electronic Publication: 2022 May 13.

Publication Type: Journal Article

Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

9
Academic Journal

Authors: Stewart MD; Friends of Cancer Research. Electronic address: mstewart@focr.org., McCall B; Genentech, A Member of the Roche Group., Pasquini M; Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research., Yang AS; Xencor., Britten CD; Amgen., Chuk M; Food and Drug Administration., De Claro RA; Food and Drug Administration., George B; Food and Drug Administration., Gormley N; Food and Drug Administration., Horowitz MM; Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research., Kowack E; Xencor., McCoy C; Bristol Myers Squibb., Morrow PK; Amgen., Okoye E; Regeneron Pharmaceuticals., Ricafort R; Bristol Myers Squibb., Rossi J; CERo Therapeutics., Sharon E; National Cancer Institute., Theoret M; Food and Drug Administration., Vegni F; Bristol Myers Squibb., Yu T; Amgen., Allen J; Friends of Cancer Research.

Source: Cytotherapy [Cytotherapy] 2022 Jul; Vol. 24 (7), pp. 742-749. Date of Electronic Publication: 2022 Feb 23.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE

10
Academic Journal

Authors: Pelosof L; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Saung MT; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Donoghue M; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Casak S; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Mushti S; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Cheng J; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Jiang X; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Liu J; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Zhao H; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Khazraee M; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Goldberg KB; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Theoret M; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Lemery S; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Pazdur R; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Fashoyin-Aje L; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Source: The oncologist [Oncologist] 2021 Apr; Vol. 26 (4), pp. 318-324. Date of Electronic Publication: 2021 Jan 11.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

PDF Full Text
11
Academic Journal

Authors: Pinato DJ; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W120HS, UK. Electronic address: david.pinato@imperial.ac.uk., Marron TU; Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA., Mishra-Kalyani PS; Office of Biostatistics, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA., Gong Y; Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA., Wei G; Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA., Szafron D; Dept of Internal Medicine, Baylor College of Medicine, Houston, TX, USA., Sharon E; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA., Saeed A; Division of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Westwood, KS, USA., Jun T; Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA., Dharmapuri S; Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA., Naqash AR; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Peeraphatdit T; Section of Gastroenterology, Hepatology & Nutrition, The University of Chicago Medicine, 5841 S. Maryland Ave., Chicago, IL, 60637, USA., Gampa A; Section of Gastroenterology, Hepatology & Nutrition, The University of Chicago Medicine, 5841 S. Maryland Ave., Chicago, IL, 60637, USA., Wang Y; Department of Gastroenterology, Hepatology & Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khan U; Division of Hematology and Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, 1305 York Avenue, Room Y1247, New York, NY, 10021, USA., Muzaffar M; Division of Hematology/Oncology, East Carolina University, 600 Moye Boulevard, Greenville, NC, 27834, USA., Navaid M; Division of Hematology/Oncology, East Carolina University, 600 Moye Boulevard, Greenville, NC, 27834, USA., Lee CJ; Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, Taipei, Taiwan., Lee PC; Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, Taipei, Taiwan., Bulumulle A; Division of Hematology/Oncology, East Carolina University, 600 Moye Boulevard, Greenville, NC, 27834, USA., Yu B; Lincoln Medical Center, 234 East 149th Street, Bronx, NY, USA., Paul S; New York Presbyterian Brooklyn Methodist Hospital, 506 6th St, Brooklyn, NY, USA., Nimkar N; New York Presbyterian Brooklyn Methodist Hospital, 506 6th St, Brooklyn, NY, USA., Bettinger D; Department of Medicine II, Faculty of Medicine, Medical Center University of Freiburg, University of Freiburg, Freiburg, Germany., Hildebrand H; Division of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Westwood, KS, USA., Abugabal YI; Dept of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pressiani T; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Milan, Pieve Emanuele, 20090, Italy., Personeni N; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Milan, Pieve Emanuele, 20090, Italy., D'Alessio A; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W120HS, UK; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Milan, Pieve Emanuele, 20090, Italy., Kaseb AO; Dept of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huang YH; Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Ang C; Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA., Schneider J; Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA., Pillai A; Section of Gastroenterology, Hepatology & Nutrition, The University of Chicago Medicine, 5841 S. Maryland Ave., Chicago, IL, 60637, USA., Rimassa L; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Milan, Pieve Emanuele, 20090, Italy; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, Milan, Rozzano, 20089, Italy., Goldberg KB; Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA., Pazdur R; Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA., Theoret M; Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA., Lemery S; Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA., Fashoyin-Aje '; Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA., Cortellini A; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W120HS, UK; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, L'Aquila, 67100, Italy. Electronic address: a.cortellini@imperial.ac.uk., Pelosof L; Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA. Electronic address: Lorraine.Pelosof@fda.hhs.gov.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Nov; Vol. 157, pp. 140-152. Date of Electronic Publication: 2021 Sep 08.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

12
Academic Journal

Authors: Amiri-Kordestani L; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring. Electronic address: Laleh.AmiriKordestani@fda.hhs.gov., Xie D; Office of Biostatistics, Division of Biometrics V, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Bloomquist E; Office of Biostatistics, Division of Biometrics V, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA., Tang S; Office of Biostatistics, Division of Biometrics V, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA., Ibrahim A; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring., Goldberg KB; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, USA., Theoret MR; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, USA., Pazdur R; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, USA., Sridhara R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, USA., Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Beaver JA; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Dec; Vol. 31 (12), pp. 1704-1708. Date of Electronic Publication: 2020 Aug 28.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

13
Editorial & Opinion

Authors: Weinstock C; Chana Weinstock, MD; Laura L. Fernandes, PhD; Marc Theoret, MD; Shenghui Tang, PhD; Rajeshwari Sridhara, PhD; Julia A. Beaver, MD; and Richard Pazdur, MD, US Food and Drug Administration, Silver Spring, MD., Fernandes LL; Chana Weinstock, MD; Laura L. Fernandes, PhD; Marc Theoret, MD; Shenghui Tang, PhD; Rajeshwari Sridhara, PhD; Julia A. Beaver, MD; and Richard Pazdur, MD, US Food and Drug Administration, Silver Spring, MD., Theoret M; Chana Weinstock, MD; Laura L. Fernandes, PhD; Marc Theoret, MD; Shenghui Tang, PhD; Rajeshwari Sridhara, PhD; Julia A. Beaver, MD; and Richard Pazdur, MD, US Food and Drug Administration, Silver Spring, MD., Tang S; Chana Weinstock, MD; Laura L. Fernandes, PhD; Marc Theoret, MD; Shenghui Tang, PhD; Rajeshwari Sridhara, PhD; Julia A. Beaver, MD; and Richard Pazdur, MD, US Food and Drug Administration, Silver Spring, MD., Sridhara R; Chana Weinstock, MD; Laura L. Fernandes, PhD; Marc Theoret, MD; Shenghui Tang, PhD; Rajeshwari Sridhara, PhD; Julia A. Beaver, MD; and Richard Pazdur, MD, US Food and Drug Administration, Silver Spring, MD., Beaver JA; Chana Weinstock, MD; Laura L. Fernandes, PhD; Marc Theoret, MD; Shenghui Tang, PhD; Rajeshwari Sridhara, PhD; Julia A. Beaver, MD; and Richard Pazdur, MD, US Food and Drug Administration, Silver Spring, MD., Pazdur R; Chana Weinstock, MD; Laura L. Fernandes, PhD; Marc Theoret, MD; Shenghui Tang, PhD; Rajeshwari Sridhara, PhD; Julia A. Beaver, MD; and Richard Pazdur, MD, US Food and Drug Administration, Silver Spring, MD.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Jan 01; Vol. 38 (1), pp. 106. Date of Electronic Publication: 2019 Nov 01.

Publication Type: Letter; Comment

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

14
Academic Journal

Authors: Howie LJ; US Food and Drug Administration, White Oak, MD., Singh H; US Food and Drug Administration, White Oak, MD., Bloomquist E; US Food and Drug Administration, White Oak, MD., Wedam S; US Food and Drug Administration, White Oak, MD., Amiri-Kordestani L; US Food and Drug Administration, White Oak, MD., Tang S; US Food and Drug Administration, White Oak, MD., Sridhara R; US Food and Drug Administration, White Oak, MD., Sanchez J; US Food and Drug Administration, White Oak, MD., Prowell TM; US Food and Drug Administration, White Oak, MD., Kluetz PG; US Food and Drug Administration, White Oak, MD., King-Kallimanis BL; US Food and Drug Administration, White Oak, MD., Gao JJ; US Food and Drug Administration, White Oak, MD., Ibrahim A; US Food and Drug Administration, White Oak, MD., Goldberg KB; US Food and Drug Administration, White Oak, MD., Theoret M; US Food and Drug Administration, White Oak, MD., Pazdur R; US Food and Drug Administration, White Oak, MD., Beaver JA; US Food and Drug Administration, White Oak, MD.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Dec 20; Vol. 37 (36), pp. 3475-3483. Date of Electronic Publication: 2019 Sep 27.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

15
Academic Journal

Authors: Maher VE; US Food and Drug Administration, Silver Spring, MD., Fernandes LL; US Food and Drug Administration, Silver Spring, MD., Weinstock C; US Food and Drug Administration, Silver Spring, MD., Tang S; US Food and Drug Administration, Silver Spring, MD., Agarwal S; US Food and Drug Administration, Silver Spring, MD., Brave M; US Food and Drug Administration, Silver Spring, MD., Ning YM; US Food and Drug Administration, Silver Spring, MD., Singh H; US Food and Drug Administration, Silver Spring, MD., Suzman D; US Food and Drug Administration, Silver Spring, MD., Xu J; US Food and Drug Administration, Silver Spring, MD., Goldberg KB; US Food and Drug Administration, Silver Spring, MD., Sridhara R; US Food and Drug Administration, Silver Spring, MD., Ibrahim A; US Food and Drug Administration, Silver Spring, MD., Theoret M; US Food and Drug Administration, Silver Spring, MD., Beaver JA; US Food and Drug Administration, Silver Spring, MD., Pazdur R; US Food and Drug Administration, Silver Spring, MD.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Oct 20; Vol. 37 (30), pp. 2730-2737. Date of Electronic Publication: 2019 May 22.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

16
Academic Journal

Authors: King-Kallimanis BL; Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: belinda.kallimanis@fda.hhs.gov., Kanapuru B; Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, MD, USA., Blumenthal GM; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Theoret MR; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Kluetz PG; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.

Source: Seminars in oncology [Semin Oncol] 2018 Aug; Vol. 45 (4), pp. 201-209. Date of Electronic Publication: 2018 Oct 25.

Publication Type: Journal Article; Review

Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0420432 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8708 (Electronic) Linking ISSN: 00937754 NLM ISO Abbreviation: Semin Oncol Subsets: MEDLINE

17
Review

Authors: Kim G; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Geoffrey.Kim@fda.hhs.gov., McKee AE; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ning YM; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Hazarika M; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Theoret M; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Johnson JR; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Xu QC; Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Tang S; Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Sridhara R; Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Jiang X; Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., He K; Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Roscoe D; Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiologic Health, U.S. Food and Drug Administration, Silver Spring, Maryland., McGuinn WD; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Helms WS; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Russell AM; Office of New Drug Quality Assessment, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Miksinski SP; Office of New Drug Quality Assessment, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Zirkelbach JF; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Earp J; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Liu Q; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ibrahim A; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Justice R; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2014 Oct 01; Vol. 20 (19), pp. 4994-5000. Date of Electronic Publication: 2014 Aug 05.

Publication Type: Letter; Review

Journal Info: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

18
Academic Journal

Authors: Vatsan RS; Office of Cellular, Tissue, and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), Rockville, MD, USA., Bross PF; Office of Cellular, Tissue, and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), Rockville, MD, USA., Liu K; Office of Cellular, Tissue, and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), Rockville, MD, USA., Theoret M; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Rockville, MD, USA., De Claro AR; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Rockville, MD, USA., Lu J; Office of Cellular, Tissue, and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), Rockville, MD, USA., Helms W; Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Rockville, MD, USA., Niland B; Office of Cellular, Tissue, and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), Rockville, MD, USA., Husain SR; Office of Cellular, Tissue, and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), Rockville, MD, USA., Puri RK; Office of Cellular, Tissue, and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), Rockville, MD, USA.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2013 May 29; Vol. 1, pp. 5. Date of Electronic Publication: 2013 May 29 (Print Publication: 2013).

Publication Type: Journal Article; Review

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: eCollection Cited Medium: Print ISSN: 2051-1426 (Print) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: PubMed not MEDLINE

19
Academic Journal

Authors: Overwijk WW; Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1502, USA., Theoret MR, Restifo NP

Source: The cancer journal from Scientific American [Cancer J Sci Am] 2000 Feb; Vol. 6 Suppl 1, pp. S76-80.

Publication Type: Journal Article; Review

Journal Info: Publisher: Scientific American, Inc Country of Publication: United States NLM ID: 9513568 Publication Model: Print Cited Medium: Print ISSN: 1081-4442 (Print) Linking ISSN: 10814442 NLM ISO Abbreviation: Cancer J Sci Am Subsets: MEDLINE